Zip Bio
Compressing Biology
Seattle, United States · Founded 2023 · $4.0M raised
- Headquarters
- Seattle, Washington
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- ziptx.bio
- Total Funding
- $4.0M
- Last Round
- $4.0M SeedSep 2024
- Rounds
- 1
About
ZipBio is a Seattle-based biotechnology startup developing a generative AI platform for gene and protein compression. Founded in 2023, the company uses AI to design compact proteins and next-generation therapeutics that overcome the size limitations of current gene therapy delivery systems. ZipBio launched publicly in September 2024 with a $4 million seed round led by NFX. The company's technology aims to compress biological sequences to enable delivery of larger genetic payloads, addressing a fundamental bottleneck in gene therapy development.
Summary
Zip Bio is an Artificial Intelligence company based in Seattle, United States, founded in 2023. It has raised $4.0M in total across 1 round, most recently a $4.0M Seed round in Sep 2024. Investors include NFX, MoreVC and Samsung Next.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Investors
Similar Companies
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Chinese AI company building large language models and conversational AI assistant Kimi
Mistral is on a mission to push AI forward, to serve the open community and their enterprise cust...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...